Form 424B5 ArriVent BioPharma, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
ArriVent BioPharma enters $250 million stock offering agreement
May 11, 2026 4:44 PM EDTArriVent BioPharma Inc. (NASDAQ: AVBP) announced it has entered into an Open Market Sale Agreement with Jefferies LLC to serve as sales agent for a potential stock offering worth up to $250 million.
Under the agreement terms, ArriVent may offer and... More
